That is very important, due to the fact that the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (diplomatic relations). However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. This was a breakthrough nearly nobody noticed. But it's going to have profound ramifications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (tech stocks). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back perhaps considerably before going greater - future report review. I've been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. But that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. the legacy report predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous terrific private companies on the edge of hitting the public markets And I've been working on a brand-new way for you to invest even before these business go public.
This opportunity has actually been developing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the details. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Diary. Regular Diary readers know that tech isn't our typical beat (the legacy report predictions). And when it concerns tech investing, we leave it to the experts. Luckily, we have several such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (tech predictions). In reality, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing rapid development and developing extraordinary opportunities for investors. I desire to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. the legacy report prediction. But regardless of what numerous readers might believe, this is a pattern that's simply getting going. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions 2021). Losing 2 months of manufacturing and sales really affects the number of 5G gadgets are sold in the calendar year. When you think about all of that, selling 250 million systems is remarkable. More significantly, the delays triggered by the pandemic developed a heap of bottled-up demand. And that demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - last year. Which's not my only 5G prediction When I have actually discussed 5G in the past, I've explained its 3 different phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be provided (jeff brown market predictions). That's when we start to see applications running on 5G networks. Think about things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage 3 by this summertime. This begins something of a virtuous cycle: Many people don't actually care about the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be enormous. Stepping away from 5G, the next important technology I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not operate correctly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For years, CRISPR was mainly a specific niche innovation that wasn't well understood. And throughout that time, there were really just 3 companies running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing amazing returns. This entire industry is successfully a greenfield chance.
There's space for numerous business to exist in this area. jeff brown 2021 predictions. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software application can precisely predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is essential due to the fact that the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has been an experimental procedure. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however a number of drug therapies produced using this technology. This was among those developments that practically nobody observed. However it's going to have profound ramifications for curing disease. And, obviously, there will be lots of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly substantially before going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - black sea. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. melania trump. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date since February 2021, however we could not separately verify this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this moment. Brown is best known for his sage-like ability to select winning innovation stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding viewpoint on the market. He's always on the hunt for new chances, and he shares much of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully forecasted a few of the greatest economic events of the previous 20 years. Although he does not appear to release his picks to the public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it right whenever, but Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a prominent financial research study publisher. Brownstone Research uses a number of research study services with a variety of specializations - genetic sequencer stock jeff brown.
The company is likewise connected with Bonner & Partners, another well-respected research publisher - first lady. On its website, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been readily available to specific financiers. It has actually been generally reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. bleeding edge. The objective of Brownstone Research is to make that type of proprietary research study offered to any financiers aiming to get an edge in the markets. The objective is simple to deliver distinct and lucrative investment research discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the company's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. jeff brown stock market prediction. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. genetic sequencing companies jeff brown. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying 2 advanced innovations: expert system and electrical vehicles. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the vehicle industry's Holy Grail. As you understand, electric cars and self-driving automobile stocks have actually been huge this year, however the Wall Street maker has been big on hype without much tangible outcome. In spite of a drastic increase in competition over the previous few years, Brown still believes Musk has the finest opportunity of putting everything together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Car, and it could be the future of transport. Essentially, this innovation would allow you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the profits. It sounds crazy, however it could be closed than you believe.